Published in Telemedicine Week, April 5th, 2005
This study is being conducted under the open investigational new drug application in the U.S. and the clinical trial application in Canada activated in October 2004.
The study will compare the accuracy of ThromboView to contrast venography in the diagnosis of patients with new and recurrent deep vein thrombosis (DVT). Contrast venography is currently regarded as the gold standard procedure for this diagnosis.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.